XML 24 R12.htm IDEA: XBRL DOCUMENT v3.3.1.900
Earnings Per Share
3 Months Ended
Jan. 31, 2016
Earnings Per Share [Abstract]  
Earnings Per Share
Earnings per Share

We compute basic earnings per share (EPS) using the daily weighted average number of shares of common stock outstanding during each period. In the calculation of fully diluted EPS, shares of common stock to be issued under approved incentive compensation plan (ICP) awards and forward sale agreements (FSAs) are contingently issuable shares, as determined by applying the treasury stock method, and are added to average common shares outstanding, resulting in a potential reduction in diluted EPS.

A reconciliation of basic and diluted EPS, which includes contingently issuable shares that could affect EPS if performance units ultimately vest and any FSAs settle, for the three months ended January 31, 2016 and 2015 is presented below.
 
Three Months
In thousands, except per share amounts
2016
 
2015
Net Income
$
97,790

 
$
92,978

 
 
 
 
Average shares of common stock outstanding for basic earnings per share
80,963

 
78,620

Contingently issuable shares under ICP awards
117

 
325

Contingently issuable restricted nonvested shares under accelerated ICP awards
182

 

Contingently issuable shares under FSAs
4

 

Average shares of dilutive stock
81,266

 
78,945

 
 
 
 
Earnings Per Share of Common Stock:
 
 
 
Basic
$
1.21

 
$
1.18

Diluted
$
1.20

 
$
1.18


 
We accelerated the issuance of shares of common stock under approved ICP awards as permitted under the terms of the Merger Agreement. This acceleration resulted in the issuance of 181,944 restricted nonvested shares of our common stock in December 2015, plus 1,092 restricted nonvested shares of our common stock from the reinvestment of dividends on these shares in January 2016. These restricted nonvested shares of our common stock are included in the calculation of diluted earnings per share in the table above but excluded in basic earnings per share and shares of our common stock outstanding because of their restricted nonvested nature. For further information on the acceleration of these shares of our common stock under our employee share-based plans, see Note 12 to the condensed consolidated financial statements in this Form 10-Q.